# THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death

Study · id `cardio:ct-nct03354429` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03354429](<https://clinicaltrials.gov/study/NCT03354429>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03354429

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 11016 participants.

## Technical summary

Registry record NCT03354429. Randomized; quadruple masking; primary purpose treatment. Start 2018-01-22 (actual); primary completion 2019-12-13 (actual). Results posted on 2020-12-22.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 11016 participants (enrolled count; ClinicalTrials.gov record NCT03354429, source copy `cardio:ctgov-nct03354429-2020-12-22`, retrieved 2026-10-26)
- Started: 2018-01-22 (actual) (ClinicalTrials.gov record NCT03354429, source copy `cardio:ctgov-nct03354429-2020-12-22`, retrieved 2026-10-26)
- Primary completion: 2019-12-13 (actual) (ClinicalTrials.gov record NCT03354429, source copy `cardio:ctgov-nct03354429-2020-12-22`, retrieved 2026-10-26)
- Completion: 2019-12-13 (actual) (ClinicalTrials.gov record NCT03354429, source copy `cardio:ctgov-nct03354429-2020-12-22`, retrieved 2026-10-26)
- Results first posted: 2020-12-22 (ClinicalTrials.gov record NCT03354429, source copy `cardio:ctgov-nct03354429-2020-12-22`, retrieved 2026-10-26)
- Countries: Argentina; Australia; Belgium; Brazil; Bulgaria; Canada; China; Czechia; France; Germany; Hong Kong SAR China; Hungary; India; Italy; Mexico; Peru; Poland; Romania; Russia; Saudi Arabia; Slovakia; South Korea; Spain; Sweden; Taiwan; Thailand; Ukraine; Vietnam (ClinicalTrials.gov record NCT03354429, source copy `cardio:ctgov-nct03354429-2020-12-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03354429-2020-12-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death
- Acronym: THALES
- Condition: Acute Ischaemic Stroke
- Condition: Transient Ischaemic Attack
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Placebo
- Lead sponsor: AstraZeneca
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: AstraZeneca (`cardio:astrazeneca`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA (`cardio:pubmed-32668111`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin (`cardio:pubmed-33198608`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial (`cardio:pubmed-33940954`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial (`cardio:pubmed-34244703`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack (`cardio:pubmed-34477459`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 636c5d7496bfe0dd6d48279aff01d985fb16f2a477961378813fd9fd0a01f4a0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
